Pharmaceutical research: New speed under the Bayer cross
Bayer's pharmaceutical division has accelerated research processes through a new organizational model, though this raises strategic questions.
Bayer's pharmaceutical division has accelerated research processes through a new organizational model, though this raises strategic questions.